Atlas Trials

A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study

Clinical trial NCT02468674 · COMPLETED

Trial details

NCT number
NCT02468674
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sarcopenia
Start date
2015-07-22
Primary completion
2018-12-03
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.